Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anja Strangfeld

Showing results (111-120 of 131) with videos related to

Pageof 14
Sort By:
Arthritis Care & Research|October 14, 2022
Association Between Race/Ethnicity and COVID-19 Outcomes in Systemic Lupus Erythematosus Patients From the United States: Data From the COVID-19 Global Rheumatology AllianceManuel F Ugarte-Gil, Graciela S Alarcón, Andrea M Seet, et al.
Annals of the Rheumatic Diseases|January 28, 2021
Factors associated with COVID-19-related death in people with rheumatic diseases: results from the COVID-19 Global Rheumatology Alliance physician-reported registryAnja Strangfeld, Martin Schäfer, Milena A Gianfrancesco, et al.
RMD Open|April 7, 2022
SARS-CoV-2 breakthrough infections among vaccinated individuals with rheumatic disease: results from the COVID-19 Global Rheumatology Alliance provider registryJean Liew, Milena Gianfrancesco, Carly Harrison, et al.
The Journal of Rheumatology|September 2, 2021
COVID-19 in Pregnant Women With Rheumatic Disease: Data From the COVID-19 Global Rheumatology AllianceBonnie L Bermas, Milena Gianfrancesco, Helen L Tanner, et al.
Annals of the Rheumatic Diseases|August 11, 2022
Consensus statement on blocking interleukin-6 receptor and interleukin-6 in inflammatory conditions: an updateDaniel Aletaha, Andreas Kerschbaumer, Kastriot Kastrati, et al.
Therapeutic Advances in Musculoskeletal Disease|July 18, 2025
Impact of conflicting information on the use of antirheumatic drugs in pregnancy and breastfeeding: perspectives of healthcare providers from the global PRAISE surveyKaren Schreiber, Christine Graversgaard, Ioannis Parodis, et al.
RMD Open|September 13, 2022
Factors associated with severe COVID-19 in people with idiopathic inflammatory myopathy: results from the COVID-19 Global Rheumatology Alliance physician-reported registrySu-Ann Yeoh, Milena Gianfrancesco, Saskia Lawson-Tovey, et al.
Annals of the Rheumatic Diseases|June 30, 2026
Mapping inequalities in rheumatology care in Europe: the first edition of the EULAR RheumaFacts projectAnna Moltó, Anastasiia Miendrova, Laure Gossec, et al.
Annals of the Rheumatic Diseases|January 24, 2020
EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2019 updateJosef S Smolen, Robert B M Landewé, Johannes W J Bijlsma, et al.
Annals of the Rheumatic Diseases|March 13, 2026
EULAR recommendations for the management of rheumatoid arthritis with synthetic and biologic disease-modifying antirheumatic drugs: 2025 updateJosef S Smolen, Christopher J Edwards, Victoria Konzett, et al.
Pageof 14

Showing results (111-120 of 131) with videos related to

Sort By:
Pageof 14
Arthritis Care & Research|October 14, 2022
Association Between Race/Ethnicity and COVID-19 Outcomes in Systemic Lupus Erythematosus Patients From the United States: Data From the COVID-19 Global Rheumatology AllianceManuel F Ugarte-Gil, Graciela S Alarcón, Andrea M Seet, et al.
Annals of the Rheumatic Diseases|January 28, 2021
Factors associated with COVID-19-related death in people with rheumatic diseases: results from the COVID-19 Global Rheumatology Alliance physician-reported registryAnja Strangfeld, Martin Schäfer, Milena A Gianfrancesco, et al.
RMD Open|April 7, 2022
SARS-CoV-2 breakthrough infections among vaccinated individuals with rheumatic disease: results from the COVID-19 Global Rheumatology Alliance provider registryJean Liew, Milena Gianfrancesco, Carly Harrison, et al.
The Journal of Rheumatology|September 2, 2021
COVID-19 in Pregnant Women With Rheumatic Disease: Data From the COVID-19 Global Rheumatology AllianceBonnie L Bermas, Milena Gianfrancesco, Helen L Tanner, et al.
Annals of the Rheumatic Diseases|August 11, 2022
Consensus statement on blocking interleukin-6 receptor and interleukin-6 in inflammatory conditions: an updateDaniel Aletaha, Andreas Kerschbaumer, Kastriot Kastrati, et al.
Therapeutic Advances in Musculoskeletal Disease|July 18, 2025
Impact of conflicting information on the use of antirheumatic drugs in pregnancy and breastfeeding: perspectives of healthcare providers from the global PRAISE surveyKaren Schreiber, Christine Graversgaard, Ioannis Parodis, et al.
RMD Open|September 13, 2022
Factors associated with severe COVID-19 in people with idiopathic inflammatory myopathy: results from the COVID-19 Global Rheumatology Alliance physician-reported registrySu-Ann Yeoh, Milena Gianfrancesco, Saskia Lawson-Tovey, et al.
Annals of the Rheumatic Diseases|June 30, 2026
Mapping inequalities in rheumatology care in Europe: the first edition of the EULAR RheumaFacts projectAnna Moltó, Anastasiia Miendrova, Laure Gossec, et al.
Annals of the Rheumatic Diseases|January 24, 2020
EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2019 updateJosef S Smolen, Robert B M Landewé, Johannes W J Bijlsma, et al.
Annals of the Rheumatic Diseases|March 13, 2026
EULAR recommendations for the management of rheumatoid arthritis with synthetic and biologic disease-modifying antirheumatic drugs: 2025 updateJosef S Smolen, Christopher J Edwards, Victoria Konzett, et al.
Pageof 14